以下文章来源于红刊财经 ，作者证券市场周刊 红刊财经 . 《证券市场周刊》创刊于1992年，我们的读者主要为职业投资人和机构投资人，内容以专业的分析和深度报道见长。 公众号 「设为星标」 ，及时获取更新内容！ 从产业角度看，在今年已经召开的两次国际学术大会上，多家内地的创新药企成为主角，展示了在研成果，从而让世界看到了中国创新药企的雄厚实 力。特别是在涉及多个细分领域的头对头临床研究中，中国内地的创新药企已经不止一次击败了该领域的全球药王，充分提振了产业人的信心。此外， 内地药企的在研管线也成为国际知名药企争抢的对象，近期三生制药和石药集团都签定了管线大单，卖出天价的同时增厚了公司业绩。 受此影响， A股和港股中的多家创新药公司二级市场表现亮眼，这边有连续十日收阳的舒泰神和股价突破300元的百利天恒，那边则有签了大单赚到真 金白银的石药集团和三生制药。 至于近期热议的创新药行情会不会昙花一现？从多数机构卖方的观点来看，答案都是否定的。毕竟从产业投资规律看，创新药赛道长期流传"双十"规 律，即从新药研发开始到最终获批上市需要平均耗时十年，投入成本约十亿美元，而目前基本到了一批企业的集中收获期了，在成为新质生产力 ...

以下文章来源于公募排排网 ，作者排排产品研究中心 公募排排网 . 看财经、查排名、买基金，就上公募排排网，申购费低至0.001折。 本文首发于公众号"公募排排网"。（点击↑↑上图查看详情） 一、监管明确导向，"固收+"迎来政策红利 2025年5月，证监会发布《推动公募基金高质量发展行动方案》，明确提出："加大含权中低波动型产品、资产配置型产品创设力度"。直指投 资者获得感提升的核心命题。 "固收+"策略作为符合这一特征的公募产品，将迎来政策红利带来的增量资金支持，或将成为直接受益者。事实上，早在今年一季度，部分机 构的"固收+"基金销量便已突破百亿元规模，政策方向与市场行为正在互相验证。 （点此查看 近五年收益10强"固收＋"公募基金名单 ） 二、利率下行加剧"理财替代需求"，"固收+"成为缓冲核心工具 近几年"固收+"策略基金受到投资者青睐，主要还是因为传统无风险理财的收益空间被快速压缩。 自2022年以来，外部环境面临较大不确定性，国内稳增长政策背景下，主要金融机构已多次降息。截至目前，多家大型股份制银行宣布活期 利率下调至0.05%，一年期存款利率已普遍跌破1%关口。 （数据来源：中国银行官网 2025 ...

Market Overview - After a rapid rise in the A-share market by the end of September 2024, the market has maintained a relatively high level of volatility over the past six months, with most major indices showing a decline [2] - The A-share indices mostly experienced a drop, with the small-cap index, CSI 2000, showing relative strength, while the Shanghai Composite Index barely closed in the green due to support from the banking sector [2] - The Hong Kong stock market performed relatively well due to cheaper valuations compared to A-shares and significant foreign capital inflows, while the US stock market saw slight declines due to high positioning and external shocks [2] Performance Summary - A-share indices performance over the past six months includes: - Shanghai Composite Index: +0.63% - Shenzhen Component Index: -5.38% - ChiNext Index: -10.38% - CSI 300: -1.95% - CSI 500: -3.09% - CSI 1000: -2.63% - CSI 2000: +2.92% - Hong Kong indices showed significant gains: - Hang Seng Index: +19.90% - Hang Seng Tech Index: +18.76% - US indices experienced slight declines: - Dow Jones Industrial Average: +5.88% - S&P 500: -2.00% - Nasdaq: -0.54% [4] Private Equity Fund Performance - Among the 507 private equity products with performance data available, the average return over the past six months was approximately 6.22%, while the average return over the past year was about 21.10% [5] - Equity strategy products accounted for over 80% of the total, with an average return of 6.57%, outperforming major A-share indices [5] - Quantitative long-only products showed an average return of over 11%, leading other strategy products, while macro strategy products followed closely with returns exceeding 9% [5] Top Performing Products - The top 10 quantitative long-only products significantly outperformed the A-share indices, with the leading product being "Longqi Stock Quantitative Long No. 1" managed by Longqi Technology, achieving near ***% returns over the past six months [7][9] - The top 10 subjective long-only products had an average return of 1.07% over the past six months, with "Rido Investment" leading the pack [10][14] - The top 10 multi-asset strategy products included "Honghu Stable Macro Hedge A Class" managed by Liang Wentao, which is the largest product by scale among the top performers [22][24] Investment Insights - Wang Wen from Rido Investment believes that the A-share market has completed its bottoming process and is entering a historical opportunity for value re-evaluation, predicting a significant upward trend [14][16] - The investment strategy focuses on five dimensions: low valuation, high cash flow, high dividends, industry growth, and positive fundamental changes, with a particular interest in the entertainment and financial sectors [16]

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 半鞅私募基金简介 半鞅私募基金 成立于 2021年9月，核心投研团队为国内最早（2018）将机器学习运用于量化选股的团队之一。 半鞅私募基金 专注于挖掘高频Alpha，并自主开发了高频交易算法和高频交易系统。目前半鞅量化策略已有超过10年的经验，机器学习策略研 发经验超7年。投研框架成熟，且策略都已经历过多轮牛熊周期的考验。公司50%自有资金跟投在资管产品中，与投资者利益长期绑定。（点此 查看 半鞅私募基金旗下产品收益、核心团队及最新路演 ） 管理规模突破5亿:上线第二代 2023年 执行算法,提升短期趋势预 测;新增DMA、多空策略、中 波CTA等产品线 管理规模突破10亿，机器学习 2024年 领域取得显著突破，灰度上线 0 第三代执行算法,上线跨期套 管理规模突破20亿,Infra、 利模块,并开发新的展期策略 Alpha策略、量化CTA策略均取 2025年 得重大进展,包括上线新一代 · 流处理引擎、即将上线新一代 分布式计算平台、提高调仓频 率、提升交易收益占比等方 面。 秒 喜排排网 y 半额 户 核心团队 核心投研团队为国内最早(2 ...

近期，A股行情再度进入震荡阶段。在贸易争端、地缘冲突等因素的影响下，投资不确定性带来 的扰动影响持续。从私募角度出发，当下市场对于数十亿甚至上百亿规模的头部私募关注度较 高，但对小微型私募关注相对较小。 私募排排网数据显示， 有业绩显示的 5亿规模以下私募在近半年、近一年、近三年、近五年分别 实现6.84%、25.29%、45.51%、93.49%的收益，整体表现明显强于大盘。 为了给予投资者更 有价值的信息，本文在5亿以下规模私募中，分别梳理出了近半年、近一年、近三年、近五年收 益的TOP20私募，供投资者参考。 0 1 近半年 " 小而美 " 私募 TOP20 ：主观扛大旗！富延资本收益遥遥领先 私募排排网数据显示，截至2025年5月底的近半年数据中，0-5亿规模有业绩显示且产品数在3只 以上的私募共196家，合计规模约为234.36亿元，近半年收益均值高达6.84%。近半年"小而美"私 募收益均值上榜TOP20的门槛为 ***%。 从投资模式来看，主观私募上榜达15家，量化私募占3 家，"主观+量化"混合类私募占2家。（ 点此查看收益 ） [应监管要求，私募产品不能公开展示业绩，文中涉及收益数据用*** ...

| 排序 | 公司简称 | 被私募调研次 数 | 5月涨跌幅(%) | | 季度持有 持有流通股数 机构持有流通股 | | 所属方向/板块 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 的机构数 | (万股) | 市值(万元 | | | 1 | 菜绅通灵 | 5 | 67.81 | 6 | 6303.03 | 41284.82 | 饰品 | | 2 | 曼卡龙 | 3 | 45.48 | 9 | 11026.41 | 131986.07 | 谷子经济、饰品 | | 3 | 潮宏基 | 3 | 45.30 | 29 | 44106.18 | 358583.23 | 盲盒经济、饰品 | | ব | | 7 | 44.16 | 3 | 514.83 | 12175.85 | 宠物经济 | | 5 | | 1 | 34.78 | 3 | 5826.66 | 83146.44 | 为泡泡玛特提供 产品设计服务 | | | 烦请扫码 | 1 | 30.36 | 3 | 25492.89 | 354606.15 | 饮料乳品 | | | | 15 ...

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 知名量化私募 靖奇投资 创始人范思奇于6月10日宣布，他将卸任靖奇投资基金经理职务，所管理的基金产品将进入清盘流程，预计本月底前完 成产品清盘。 范思奇透露，近年来市场环境变化迅速，给他带来身心压力。同时，管理公司事务等工作占用了他大部分时间，影响生活质量，也让他失去最初 的热情与乐趣。不过，他计划继续从事交易相关工作，只是不再以公司形式参与。值得关注的是，范思奇表示当前股市比持有现金机会更好。 私募排排网采访靖奇投资相关人士称，本次涉及到清盘流程的基金主要为范总个人管理的自营产品，占公司总管理规模的比例不大，公司会妥善 处理相关事宜。 公司去年以来陆续引入了多位新 pm 扩充产品线，目前投研团队充沛，且策略运行良好，资管业务并不受影响。后续公司股权 结构可能会调整，提升其他合伙人股权占比和团队激励。 私募排排网数据显示， 靖奇投资 成立于 2015 年 3 月 9 日，同年8月完成备案登记，目前公司有 17 名全职员工，管理规模10-20 亿元。 经股权穿透，范思奇是公司第一大股东，公司另一位创始人唐靖人，早年在南华期货海外事业部担任经理，后与 ...

Core Viewpoint - In the past six months, private quantitative products have attracted significant investment due to the continued dominance of small-cap growth styles and breakthroughs in AI investment technology [1] Summary by Sections Performance of Quantitative Products - As of the end of May this year, there are 1,640 quantitative products with reported performance, with an average return of 6.95% and a median return of 6.5% over the past six months [1] - Among the core strategies, stock strategy products lead with 914 products, achieving an average return of 8.38% and a median return of 8.18% [1] Company Performance - A total of 179 private companies have at least three quantitative products that meet ranking criteria, with average returns of 7.16% and 7% for the past six months and this year, respectively [3] Top Performing Private Equity Firms - The article categorizes private equity firms based on six asset size groups, highlighting the top 10 performing firms in terms of average returns for each group [5] 100 Billion and Above - In the 100 billion and above category, 28 firms have an average return of ***%, with the top five being Evolutionary Asset, Ningbo Huansheng Quantitative, Xinhong Tianhe, Longqi Technology, and Abama Investment [6][7] 50-100 Billion - In the 50-100 billion category, 18 firms have an average return of ***%, with the top five being Shenzhen Liangdao Investment, Loshu Investment, Qianyan Private Equity, Square and Investment, and Tianxuan Quantitative [11][13] 20-50 Billion - In the 20-50 billion category, 27 firms have an average return of ***%, with the top five being Yunqi Quantitative, Hainan Shengfeng Private Equity, Luxiu Investment, Shengguanda, and Guangzhou Shouzheng Youqi [15][16] 10-20 Billion - In the 10-20 billion category, 26 firms have an average return of ***%, with the top five being Boyi Asset, Anzi Fund, Fox Investment, Leiang Asset, and Oak Asset [19][20] 5-10 Billion - In the 5-10 billion category, 37 firms have an average return of ***%, with the top five being Guangyi Wanda Private Equity, Shanghai Yuanlai Private Equity, Zhongmin Huijin, Wuliang Capital, and Yihe Investment [23][24] 0-5 Billion - In the 0-5 billion category, 43 firms have an average return of ***%, with the top five being Xizong (Shanghai) Private Equity, Tanglong Asset, Guangzhou Tianzhanhan, Tianzhihui Investment, and Huacheng Private Equity [28]

本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 0 1 百亿私募年内持续加仓，做多意愿强烈 私募排排网数据显示，截至2025年5月30日， 百亿私募仓位指数已达80.28%，突破80%大关。 较4月末的76.18%显著提升4.1%。值得注意的是，自去年年 底以来，百亿私募的仓位呈现持续攀升态势。 与2024年末70.27%的仓位水平相比，目前已累计加仓10.01%，这一数据充分反映出百亿私募对后市行情的 乐观预期。 融智投资 FOF基金经理李春瑜分析指出，百亿私募今年以来持续加仓主要基于三方面考量：首先，政策面持续释放积极信号，市场预期明显改善，有效 提振了投资者的信心；其次，当前A股市场整体估值处于历史合理偏低区间，底部特征显著，且经历多次探底回升，为布局具备长期投资价值的优质标的 提供了良好窗口期；此外，市场结构性机会突出，特别是以AI、半导体、消费电子、人工智能为代表的科技领域优质企业，正迎来难得的配置机遇。 0 2 超六成百亿私募满仓 私募排排网数据显示，截至 2025年5月30日， 当前60.96%的百亿私募仓位处于满仓水平 ，26.07%的百亿私募仓位处于中等水平，另外10.83% ...

Core Viewpoint - The domestic nuclear fusion sector is experiencing significant advancements, leading to increased market interest and a surge in nuclear power stocks, with companies like Baili Electric and Xuzhou Special Materials seeing substantial price increases. The long-term narrative for nuclear power is being strengthened by both domestic developments and international initiatives, particularly in the U.S. [2][3][4] Market Development Space - As of 2023, nuclear power accounts for less than 5% of China's total electricity generation, significantly lower than the global average, indicating substantial growth potential for the sector. In contrast, countries like France and Russia have much higher percentages of nuclear energy in their energy mix [2][3]. Recent Domestic Developments - On March 28, the "China Fusion Reactor No. 3" achieved a breakthrough by reaching temperatures of "double hundred million degrees," marking a significant milestone in controlled nuclear fusion technology [3]. - The State Council approved the construction of 10 new nuclear power units, expected to drive over 200 billion yuan in investments, continuing a trend of approving more than 10 units annually for four consecutive years [4]. - The BEST project in Hefei commenced construction ahead of schedule, aiming to demonstrate fusion energy generation [4]. - The China National Nuclear Corporation is entering a substantive operational phase, as indicated by new bidding projects on its website [4]. International Developments - On May 23, U.S. President signed executive orders to boost the nuclear energy sector, planning to initiate the construction of 10 large nuclear power plants by 2030 and quadruple nuclear capacity by 2050 [4][5]. Shift Towards Nuclear Energy by Tech Companies - Geopolitical conflicts have heightened the focus on energy security, prompting tech giants like Microsoft, Google, and Amazon to invest in nuclear energy solutions to meet rising energy demands driven by AI and data centers [5][6]. - Meta has signed a 20-year nuclear power purchase agreement with Constellation Energy, while Microsoft plans to restart the Three Mile Island nuclear plant [6][7]. Small Modular Reactors (SMRs) - SMRs are gaining traction as flexible nuclear power solutions for data centers, offering advantages such as modular design and shorter construction times compared to traditional nuclear plants [7][8]. - The "Linglong One" is noted as the world's first commercial modular small reactor, marking a significant development in China's nuclear capabilities [8]. Institutional Investment Trends - In the first quarter, eight nuclear power stocks saw their prices double, indicating strong institutional interest in the sector [10]. - Notably, one company had 5 institutions holding 13.32 million shares, a significant increase from the previous quarter, reflecting a growing confidence in nuclear energy investments [11]. Performance of Nuclear Stocks - Among 271 nuclear-related stocks, only 11 companies reported over 50% year-on-year growth in revenue and net profit in the first quarter, highlighting the potential for strong performance in the sector [13]. - The stock performance of certain companies has been impressive, with some achieving over 100% growth in revenue and net profit [14]. Valuation Insights - A total of 21 nuclear stocks have a price-to-earnings ratio below 20%, indicating potential undervaluation in the market [15]. - One company reported a price-to-earnings ratio of 7.22, placing it in the 7.96th percentile historically, suggesting it may be undervalued compared to its peers [16].